If you think you’ve noticed more and more retractions at PLoS ONE recently, you’re not wrong.
The journal retracted 53 papers last year. That’s not a record — that belongs to a journal that retracted more than 400 papers at once — nor is it that many more than the Journal of Biological Chemistry, which retracted 39 last year. And it’s only about 3% of the year’s retractions. But it’s a dramatic increase, as this graphic shows: Continue reading How one journal became a “major retraction engine”
According to the internet, Bear Grylls, the TV survivalist, said he “was always brought up to have a cup of tea at halfway up a rock face.” Which sounds too cute to be true and, given Grylls’ history of, um, buffing the hard edges of reality, almost certainly isn’t.
But Grylls appears to be far from alone in his tea hyperbole. A group of researchers in India has lost their 2011 paper in PLoS ONE on the synergistic effects of black tea and resveratrol — the compound in red wine touted as a fountain of youth — on skin cancer for what (if we’re allowed to read the tea leaves) amounts to a cuppa apparent data fabrication.
Weak tea, indeed. And in mice, we should note, in a nod to “data thug” James Heathers’ most recent venture. Continue reading Maybe combining red wine and tea doesn’t kill tumors after all
PLoS ONE has retracted a meta-analysis on mindfulness after determining that the authors used dubious methodology and failed to adequately report their financial interest in the psychological treatment the article found effective.
The article, “Standardised mindfulness-based interventions in healthcare: An overview of systematic reviews and meta-analyses of RCTs,” appeared in April 2015 and has been cited 130 times, according to Clarivate Analytics’ Web of Science, earning it a “highly cited paper” designation.
The authors, from Erasmus Medical Center in the Netherlands and Harvard University, included Herbert Benson, of the Benson-Henry Institute for Mind Body Medicine at Massachusetts General Hospital. The institute (which has taken down its link to the paper) offers a raft of services for patients, including a Stress Management and Resiliency Program, a Mind Body Program for Health and Fertility, a Mind Body Program for Cancer, yoga, Tai Chi and initiatives to help foster “resilient youth.”
The decision comes after a long effort by James Coyne, an emeritus professor of psychology in psychiatry at the University of Pennsylvania, to expose the undisclosed conflicts and other serious problems in the work and other studies with ties to Benson-Henry. Continue reading PLOS ONE pulls highly cited mindfulness paper over undeclared ties, other concerns
The stars did not align for a 2016 paper ancient astronomy in the Amazon region after the author discovered errors in his work that the journal deemed fatal to the case, although the author has objected to the retraction.
And the author feels as though he was punished for being honest.
The article, “Solar-Aligned Pictographs at the Paleoindian Site of Painel do Pilão along the Lower Amazon River at Monte Alegre, Brazil,” was written by Christopher Davis, then at Northern Illinois University in Dekalb, and appeared in PLOS ONE. According to the abstract: Continue reading Author of retracted PLOS ONE paper wonders if he was punished for being honest
We have news of two upcoming retractions, both following critiques on PubPeer.
PLOS ONE is retracting a 2012 paper by researchers at the Istituto Superiore di Sanità in Rome and the World Health Organization’s International Agency for Research on Cancer in Lyon, France, “Interferon-β Induces Cellular Senescence in Cutaneous Human Papilloma Virus-Transformed Human Keratinocytes by Affecting p53 Transactivating Activity.”
PubPeer commenters first left critiques of the paper on August 6 of last year, noting likely splicing and other manipulation of images. Several days later, pseudonymous whistleblower Claire Francis contacted the journal to flag similar issues. On Wednesday of this week, a journal representative emailed Francis to say the paper would be retracted: Continue reading “All very painful:” Two retractions to watch for, in eLife and PLOS ONE
PLOS ONE has retracted two papers for image problems, which we’ve learned were brought to the journal’s attention more than four years ago.
The first article came from a group of cancer researchers in China, and it turns out to have a bit more wrong than a few dodgy figures. The second also involved cancer research.
Asked about the delay, PLOS ONE told Retraction Watch: Continue reading “We regret our delay:” PLOS ONE retracts two papers
A researcher who studied natural products for cancer at the University of Alabama, Birmingham (UAB), had six papers retracted last month, bringing him to a total of 12.
Four of the recently retracted papers by Santosh Katiyar had appeared in PLOS ONE, and two had been published in Cancer Research. They have together been cited more than 250 times, according to Clarivate Analytics’ Web of Science, and are on subjects including compounds found in grape seeds and green tea.
Here’s an example, from PLOS ONE, for “Green Tea Catechins Reduce Invasive Potential of Human Melanoma Cells by Targeting COX-2, PGE2 Receptors and Epithelial-to-Mesenchymal Transition:” Continue reading Former UAB natural products researcher up to a dozen retractions
On June 25, 2015, following an investigation into the work of a then-graduate student at University College Cork in Ireland, the senior author of a 2014 paper in PLOS ONE requested its retraction. The paper, said senior author Zubair Kabir in an email to Iratxe Puebla, the journal’s managing editor, was “fundamentally flawed.”
Puebla responded on July 1, saying she would contact the graduate student — Olurotimi Bankole Ajagbe, corresponding author of the paper — and get back to Kabir. A few more emails, including one on Aug. 26, 2015, in which Ajagbe also requested the retraction, resulted. On August 31, Puebla wrote to Ivan Perry, head of Cork’s department of public health, where Ajagbe had been working on his PhD, to say she would discuss the case with colleagues and follow up.
And then Cork waited. Continue reading The waiting game: A university requests a retraction. Then it waits three years.
A professor specializing in the health of children and pregnant women has left her post at the University of Glasgow, and issued three retractions in recent months.
All three notices — issued by PLOS ONE — mention an investigation at the university, which found signs of data manipulation and falsification. Fiona Lyall, the last author on all three papers, is also the only author in common to all three papers; she did not respond to the journal’s inquiries.
According to the University of Glasgow, the affiliation listed for Lyall, she is no longer based at the university. When we asked about the circumstances of her departure, the spokesperson told us the university has a “commitment to confidentiality,” but noted:
Continue reading Glasgow professor leaves post amidst multiple retractions
A year ago, PLOS ONE published a study claiming that there was strong evidence that a person wrapped in the Shroud of Turin — according to lore, the burial shroud of Jesus Christ — had suffered “strong polytrauma.”
Today, they retracted it.
According to the retraction notice for “Atomic resolution studies detect new biologic evidences on the Turin Shroud,” Continue reading Over authors’ objections, PLOS ONE retracts paper claiming Shroud of Turin showed evidence of trauma